Study at a glance
Can vitamin D supplements reduce respiratory infections?
Researchers asked whether vitamin D supplements reduced the chance of getting an infection in the breathing system. They combined information about each person from 25 trials involving more than 10,000 people. The trials included different ages and countries. People received vitamin D, a placebo with no active treatment, or no supplement.
Which groups had fewer infections with vitamin D?
The combined results showed a lower chance of having at least one respiratory infection among people given vitamin D. The reduction met the study’s statistical test. The strongest protection was seen in people with low vitamin D levels before treatment. Daily or weekly treatment showed more benefit than occasional large doses in the trials studied.
Why might protection from infection differ between people?
The trials differed in how long they lasted, the doses used and how infections were identified. Some trials were too small to give reliable answers about particular groups. The findings do not show that everyone would receive the same protection.
What can these results tell us about taking vitamin D?
The review supports a reduction in the infections measured under these trial conditions. It did not establish protection against a particular virus or explain exactly how immune cells were affected. It also did not test vaccine responses. These results do not provide a personal treatment or dosing plan.
Read the full article below ↓Evidence from a single, verified study evaluated using a fixed, auditable study-page structure.
Study classification and identity
Study type
Individual participant data meta-analysis of randomized controlled trials
Parent study
Not applicable in this study
Ancillary study focus
System-level immune protection against acute respiratory infections
Exposure type
Randomized supplementation exposure
Intervention arms or exposure groups
Vitamin D supplementation versus placebo or no supplementation
Primary endpoint category
Clinical infectious disease outcomes
Clinical endpoints assessed
Incidence of acute respiratory infections
Study purpose and framing
This study assessed whether vitamin D supplementation reduces the risk of acute respiratory infections across diverse populations by pooling individual participant data from multiple randomized controlled trials.
The endpoint was framed as a measure of population-level immune resistance to common infectious stressors rather than as disease-specific therapeutic efficacy.
Why the primary measure is used as a biological marker
Acute respiratory infection incidence captures the integrated performance of innate and adaptive immune responses under repeated environmental pathogen exposure.
At the group level, reduced infection risk reflects enhanced immune robustness and resilience rather than isolated immunological pathway activation.
Measurement context relevant to this endpoint includes heterogeneity in exposure risk, baseline vitamin D status, and supplementation regimen across trials.
Study overview
Data were drawn from 25 randomized controlled trials including over 10,000 participants across multiple countries, age groups, and baseline vitamin D strata.
Participants receiving vitamin D supplementation were compared with control groups receiving placebo or no intervention.
Study design and measurement approach
Individual participant data were harmonized to allow consistent outcome definitions, covariate adjustment, and subgroup analyses across trials.
Key constraints include variability in dosing schedules, trial duration, and infection ascertainment methods.
Outcome hierarchy
Directly measured
Occurrence of at least one acute respiratory infection
Not measured
Cellular immune function, cytokine profiles, vaccine responses
Not inferable from this study
Individual clinical treatment recommendations or pathogen-specific immunity
Statistical analysis
A one-step individual participant data meta-analysis was used to estimate adjusted odds ratios for infection risk.
Models adjusted for age, sex, baseline vitamin D status, dosing frequency, and trial clustering.
Results
Vitamin D supplementation was associated with a statistically significant reduction in the risk of acute respiratory infections, with the strongest protective effect observed in individuals with low baseline vitamin D levels.
Daily or weekly dosing regimens showed greater benefit than intermittent high-dose bolus supplementation.
Measurement considerations and limitations
Outcome definitions and surveillance intensity varied between trials, potentially influencing absolute risk estimates.
Not all trials were powered for subgroup analyses, and residual confounding cannot be fully excluded.
Generalisability and population context
Findings apply most directly to general populations exposed to routine respiratory pathogens, particularly those with low baseline vitamin D status.
Generalisability to severe immunocompromise or specific viral pathogens is limited.
Mechanistic inference boundary
Mechanistic immune pathways were not directly tested in this analysis.
Observed effects are consistent with hypotheses of vitamin D: supported immune resilience but cannot confirm specific cellular mechanisms.
Interpretation within vitamin D physiology
The findings support a role for adequate vitamin D status in maintaining immune robustness under repeated infectious stressors.
For relevant physiology background, see Vitamin D and Immune Resilience.
Interpretation
This study supports an association between vitamin D supplementation and reduced susceptibility to acute respiratory infections at the population level.
Further work is required to define pathogen-specific effects and to link clinical outcomes with underlying immune mechanisms.
Primary source and publication details
Martineau AR, Jolliffe DA, Hooper RL, et al.
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data.
BMJ. 2017.
DOI: Not applicable in this study
https://pubmed.ncbi.nlm.nih.gov/28202713/
Related reading
Acute Respiratory Tract Infection and 25-Hydroxyvitamin D Concentration: A Systematic Review and Meta-Analysis
To review the link between 25(OH)D concentration and ARTI, we searched PubMed and EMBASE databases to identify observational studies reporting the association between 25(OH)D concentration and risk or severity of ARTI.
Original paper ↗Read more →Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
To assess the association between vitamin D deficiency and increased morbidity/mortality with COVID-19 respiratory dysfunction.
Original paper ↗Read more →Clinical Study of Vitamin D Levels in Hospitalized Children with Acute Respiratory Infections
The aim of our research was to evaluate and analyze serum 25(OH) vitamin D and parathyroid hormone (PTH) levels to investigate whether vitamin D deficiency serves as a risk factor for an increased incidence of acute respiratory infections (ARI) in children.
Original paper ↗Read more →Contemporary nutrition-based interventions to reduce risk of infection among elderly long-term care residents: A scoping review
Elderly long-term care residents (ELTCRs) face considerable burden of infection, especially evident during the COVID-19 pandemic.
Original paper ↗Read more →Effects of Maternal Vitamin D Supplementation During Pregnancy and Lactation on Infant Acute Respiratory Infections: Follow-up of a Randomized Trial in Bangladesh
We examined the effect of maternal vitamin D supplementation during pregnancy and lactation on risk of acute respiratory infection (ARI) in infants up to 6 months of age in Bangladesh.
Original paper ↗Read more →Effects of Vitamin D Supplementation and Baseline Vitamin D Status on Acute Respiratory Infections and Cathelicidin: A Randomized Controlled Trial
In the RCT study, the participants were randomized into 2 groups to receive either 20 µg of vitamin D3 or an identical placebo daily.
Original paper ↗Read more →Exercise behavior, practice, injury, and symptoms of respiratory tract infection of 502 Brazilian adults during lockdown oscillations in two years (2021 to 2022) of the COVID-19 pandemic
Participants: A total of 502 adults were evaluated during two consecutive years of the COVID-19 pandemic, corresponding to the years 2021 and 2022.
Original paper ↗Read more →Intake of 25-Hydroxyvitamin D3 May Reduce the Severity of Upper Respiratory Tract Infection: Post hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study
The Wisconsin Upper Respiratory Symptom Survey-21 was used to determine URTI.
Original paper ↗Read more →Search for Potential VDR/Partner Composite Elements in Regulatory DNA of Genes Associated with Respiratory Infections and Atopic Diseases
Vitamin D deficiency is associated with the risk of atopic diseases and respiratory infections.
Original paper ↗Read more →Serum 25-Hydroxy Vitamin D Levels in Children with Acute Respiratory Infections Caused by Respiratory Virus or Atypical Pathogen Infection
We aimed to clarify the involvement of vitamin D status in virus or atypical pathogens infection in children with acute respiratory infections (ARIs).
Original paper ↗Read more →Serum 25-hydroxyvitamin D levels in patients with Granulomatosis with Polyangiitis: association with respiratory infection
Thirty-two granulomatosis with polyangiitis patients were evaluated in the winter/spring, and the same patients (except 5) were evaluated in summer/autumn (n=27).
Original paper ↗Read more →The association between early-life respiratory infections and childhood asthma: a meta-analytic perspective
The research team examined 51 studies which they categorized into eight different research areas.
Original paper ↗Read more →The effectiveness of interventions to reduce the transmission of acute respiratory infections in care homes: a systematic review
We conducted a systematic review of randomized controlled trials, to determine which interventions (apart from vaccines) are effective at reducing transmission of acute respiratory illnesses (ARIs) in care homes.
Original paper ↗Read more →The long-term prognostic value of serum 25(OH)D, albumin, and LL-37 levels in acute respiratory diseases among older adults
Older adults are more susceptible to respiratory tract infection than healthy working age adults.
Original paper ↗Read more →The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer
The role of vitamin D (VitD) in calcium and bone homeostasis is well described.
Original paper ↗Read more →Vitamin D: A Nutraceutical Supplement at the Crossroad Between Respiratory Infections and COVID-19
Even though in mid-2023 the World Health Organization declared the end of the public health emergency of international concern status for COVID-19, many areas of uncertainty about SARS-CoV-2 infection pathophysiology remain.
Original paper ↗Read more →Vitamin D and respiratory tract infections in childhood
The main aim of this review is to summarize the current evidence from the literature about the link between vitamin D and RTIs in children.
Original paper ↗Read more →Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19
In consideration of the role of vitamin D in the immune system, aim of this study was to analyse vitamin D levels in patients with acute respiratory failure due to COVID-19 and to assess any correlations with disease severity and prognosis.
Original paper ↗Read more →Vitamin D Modulation of the Innate Immune Response to Paediatric Respiratory Pathogens Associated with Acute Lower Respiratory Infections
Vitamin D is an essential component of immune function and childhood deficiency is associated with an increased risk of acute lower respiratory infections (ALRIs).
Original paper ↗Read more →Vitamin D supplementation for prevention of acute respiratory infections in older adults: A systematic review and meta-analysis
Therefore, we systematically reviewed evidence from randomized controlled trials (RCTs) to evaluate the efficacy and safety of vitamin D supplementation in preventing ARIs in older adults.
Original paper ↗Read more →Vitamin D supplementation improves well-being in patients with frequent respiratory tract infections: a post hoc analysis of a randomized, placebo-controlled trial
The aim of this study was to test the hypothesis that vitamin D supplementation improves well-being in patients with frequent respiratory tract infections (RTIs).
Original paper ↗Read more →Original sources
https://pubmed.ncbi.nlm.nih.gov/28202713/
https://pubmed.ncbi.nlm.nih.gov/28202713/.
Publication details
https://pubmed.ncbi.nlm.nih.gov/28202713/